Enveda Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis (NCT07643766) | Enveda Therapeutics | 2026-06-29 |
| ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults (NCT07301255) | Enveda Therapeutics | 2026-01-09 |
| Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis (NCT07298395) | Enveda Therapeutics | 2025-12-22 |
| Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis (NCT07336940) | Enveda Therapeutics | 2025-09-10 |
Track Enveda Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.